Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials

被引:6
|
作者
Boren, David [1 ]
Sullivan, Patrick S. [2 ]
Beyrer, Chris [3 ]
Baral, Stefan D. [3 ]
Bekker, Linda-Gail [4 ,5 ]
Brookmeyer, Ron [1 ]
机构
[1] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA
[4] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa
[5] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa
关键词
community randomized trials; epidemics; HIV; networks; sample size; MEN; SEX; INFECTION; INTERVENTION; CLUSTER; CHALLENGES;
D O I
10.1002/sim.6193
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Important sources of variation in the spread of HIV in communities arise from overlapping sexual networks and heterogeneity in biological and behavioral risk factors in populations. These sources of variation are not routinely accounted for in the design of HIV prevention trials. In this paper, we use agent-based models to account for these sources of variation. We illustrate the approach with an agent-based model for the spread of HIV infection among men who have sex with men in South Africa. We find that traditional sample size approaches that rely on binomial (or Poisson) models are inadequate and can lead to underpowered studies. We develop sample size and power formulas for community randomized trials that incorporate estimates of variation determined from agent-based models. We conclude that agent-based models offer a useful tool in the design of HIV prevention trials. Copyright (C) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:3894 / 3904
页数:11
相关论文
共 50 条
  • [1] HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials
    Phanuphak, Nittaya
    Lo, Ying-Ru
    Shao, Yiming
    Solomon, Sunil Suhas
    O'Connell, Robert J.
    Tovanabutra, Sodsai
    Chang, David
    Kim, Jerome H.
    Excler, Jean Louis
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (11) : 1060 - 1076
  • [2] HIV prevention trials network
    Stephenson, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07): : 822 - 822
  • [3] Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials
    Cantos, Valeria D.
    Neradilek, Moni
    Huang, Yunda
    Roxby, Alison C.
    Gillespie, Kevin
    deCamp, Allan C.
    Karuna, Shelly T.
    Edupuganti, Srilatha
    Gallardo-Cartagena, Jorge
    Sanchez, Jorge
    del Rio, Carlos
    Veloso, Valdilea
    Cohen, Myron S.
    Donnell, Deborah J.
    Corey, Lawrence
    Kelley, Colleen F.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [4] Accomplishments in HIV prevention science: implications for stemming the epidemic
    Ronald O Valdiserri
    Lydia L Ogden
    Eugene McCray
    [J]. Nature Medicine, 2003, 9 : 881 - 886
  • [5] The methamphetamine epidemic: implications for HIV prevention and treatment.
    Colfax G.
    Shoptaw S.
    [J]. Current HIV/AIDS Reports, 2005, 2 (4) : 194 - 199
  • [6] Accomplishments in HIV prevention science: implications for stemming the epidemic
    Valdiserri, RO
    Ogden, LL
    McCray, E
    [J]. NATURE MEDICINE, 2003, 9 (07) : 881 - 886
  • [7] Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052
    Forsyth, Andrew D.
    Valdiserri, Ronald O.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2012, 7 (02) : 111 - 116
  • [8] Measuring effectiveness in community randomized trials of HIV prevention
    Hallett, T. B.
    Garnett, G. P.
    Mupamberiyi, Z.
    Gregson, S.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (01) : 77 - 87
  • [9] Engaging community stakeholders in preparation for HIV Vaccine Trials Network (HVTN) 703/HIV Prevention Trials Network (HPTN) 081, an antibody mediated biomedical HIV prevention trial in sub-Saharan Africa
    Lucas, J.
    Karuna, S.
    Hinson, K.
    Sista, N.
    Yola, N.
    Ntombela, F.
    Mgodi, N.
    Luthuli, N.
    Wakefield, S.
    Andrew, P.
    Greene, E.
    Delany-Moretlwe, S.
    Gray, G.
    White, R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [10] COMMUNITY PROVIDERS' IMPRESSION OF HIV PREVENTION INTERVENTION RESEARCH IN NIDA'S CLINICAL TRIALS NETWORK
    Campbell, Aimee N. C.
    Hartzler, Bryan
    Hatch-Maillette, Mary
    Calsyn, Donald A.
    Miele, Gloria M.
    Tross, Susan
    [J]. JOURNAL OF DRUG ISSUES, 2011, 41 (04) : 441 - 459